266 related articles for article (PubMed ID: 33229297)
21. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
Calabrese D; Bille J; Sanglard D
Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
[TBL] [Abstract][Full Text] [Related]
22. β-lapachone and α-nor-lapachone modulate Candida albicans viability and virulence factors.
Moraes DC; Curvelo JAR; Anjos CA; Moura KCG; Pinto MCFR; Portela MB; Soares RMA
J Mycol Med; 2018 Jun; 28(2):314-319. PubMed ID: 29598974
[TBL] [Abstract][Full Text] [Related]
23. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
24. Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae.
Reis de Sá LF; Toledo FT; de Sousa BA; Gonçalves AC; Tessis AC; Wendler EP; Comasseto JV; Dos Santos AA; Ferreira-Pereira A
BMC Microbiol; 2014 Jul; 14():201. PubMed ID: 25062749
[TBL] [Abstract][Full Text] [Related]
25. Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of
Li X; Zhao Y; Huang X; Yu C; Yang Y; Sun S
Front Cell Infect Microbiol; 2017; 7():124. PubMed ID: 28439502
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
[TBL] [Abstract][Full Text] [Related]
27. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
[TBL] [Abstract][Full Text] [Related]
28. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
29. Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans.
Kohli A; Gupta V; Krishnamurthy S; Hasnain SE; Prasad R
J Biosci; 2001 Sep; 26(3):333-9. PubMed ID: 11568478
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
Kalkandelen KT; Doluca Dereli M
Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium.
Tanabe K; Lamping E; Adachi K; Takano Y; Kawabata K; Shizuri Y; Niimi M; Uehara Y
Biochem Biophys Res Commun; 2007 Dec; 364(4):990-5. PubMed ID: 17967417
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Jatrophane Esters from Euphorbia spp. as Modulators of Candida albicans Multidrug Transporters.
Esposito M; Nim S; Nothias LF; Gallard JF; Rawal MK; Costa J; Roussi F; Prasad R; Di Pietro A; Paolini J; Litaudon M
J Nat Prod; 2017 Feb; 80(2):479-487. PubMed ID: 28106996
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
Huang S; Cao YY; Dai BD; Sun XR; Zhu ZY; Cao YB; Wang Y; Gao PH; Jiang YY
Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205
[TBL] [Abstract][Full Text] [Related]
35. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
Gulat S; Doluca Dereli M
Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
[TBL] [Abstract][Full Text] [Related]
36. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
Coste AT; Ramsdale M; Ischer F; Sanglard D
Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
[TBL] [Abstract][Full Text] [Related]
37. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant
Xu J; Liu R; Sun F; An L; Shang Z; Kong L; Yang M
Front Cell Infect Microbiol; 2019; 9():211. PubMed ID: 31281800
[TBL] [Abstract][Full Text] [Related]
38. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
Bhattacharya S; Sobel JD; White TC
Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
[TBL] [Abstract][Full Text] [Related]
39. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.
Wirsching S; Michel S; Morschhäuser J
Mol Microbiol; 2000 May; 36(4):856-65. PubMed ID: 10844673
[TBL] [Abstract][Full Text] [Related]
40. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against
Chen X; Shi Y; Li Y; Su S; Wang P; Sun S
Expert Rev Anti Infect Ther; 2021 Jan; 19(1):109-115. PubMed ID: 32924656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
